Investment Memorandum · Preview
For informational purposes only. Not investment advice.
CMC Materials, Inc.
CCMP
June 1, 2026
CMC Materials, Inc. (NASDAQ: CCMP), formerly Cabot Microelectronics, was the world's largest supplier of CMP slurries—colloidal nanoparticle suspensions used as a critical, non-substitutable input in every advanced semiconductor manufacturing process. The company also produced CMP pads, ultra-high-purity electronic chemicals (via its 2018 acquisition of KMG Chemicals), and legacy pipeline performance chemicals. Headquartered in Aurora, Illinois with major manufacturing in Rayong, Thailand, CCMP served virtually every major semiconductor manufacturer globally, with TSMC and Samsung jointly representing ~30% of revenue. At acquisition (FY2021), revenue was $1.22B with adjusted EBITDA of ~$355M (29% margin), net debt of ~$1.13B (3.2x leverage), and 27.5M diluted shares outstanding.
▲ Bull Case
- ◆Node complexity inflation is structural and accelerating—CMP steps per wafer have grown from ~8 at 130nm to 28+ at 3nm, meaning CCMP/ENTG revenue grows even with flat wafer volumes; this drives 8–12% organic semiconductor segment growth across cycles.
- ◆Customer qualification lock-in is the deepest moat in the semiconductor supply chain—18–24-month requalification cycles plus yield-loss risk on $25K–$250K wafer lots make displacement nearly impossible at the formulation level; CCMP held tungsten share at ~45% for 20+ consecutive years through three competitive cycles.
- ◆Deleveraging trajectory pre-acquisition was on plan—net debt fell from $1.55B (FY2019) to $1.13B (FY2021), with management on pace to reach <2x by FY2024 and net cash by FY2026 standalone; the deleverage plus re-rating thesis was structurally intact at sale.
▼ Bear Case
- ◆2022–2023 semiconductor downturn would have impaired standalone CCMP financially—memory CMP volumes (30–35% of revenue) dropped 15–25% in the actual cycle; with $1.1B of debt, FCF would have compressed to ~$130M and the stock likely would have traded to $70–90 range before recovery.
- ◆China revenue attrition is accelerating and structurally adverse—Anji Technology is gaining qualified positions at SMIC/YMTC mature nodes; US-China export controls could eliminate $100–150M revenue exposure within 5 years; this risk had no clear hedge and was actively worsening through 2022.
- ◆KMG acquisition permanently impaired the equity narrative—the $1.5B in goodwill, ~$90M/year of amortization, and the lower-margin pipeline/electronic chemicals segments compressed CCMP's reported ROIC from ~22% (pure-play) to ~11.5% (post-KMG), capping the trading multiple at 15–18x EBITDA versus 22–25x for a pure-play comp.
“The central debate (pre-acquisition) was timing of the deleverage-driven re-rating versus cyclical risk and China attrition. Bulls argued CCMP was a $150–180 stock on a 24-month standalone path once leverage reached <2x and the company could resume aggressive buybacks. Bears argued the imminent semi downturn plus China headwinds plus sub-IG credit profile created enough near-term risk to keep the stock range-bound at $90–115 for another 18 months—making the $133 cash exit a clearly attractive risk-adjusted outcome. The Entegris deal effectively resolved this debate by paying the bull case in cash without bull-case execution risk.”
- ◆Debt repayment to <2.5x leverage (FY2023)—multiple re-rating; removal of credit risk discount
- ◆TSMC 3nm ramp (high-volume) (2023–2024)—organic revenue +8–12% uplift
- ◆Intel foundry customer win (2023+)—new fab qualification equals long-term revenue stream
- ◆Buyback acceleration post-deleverage (2024+)—EPS accretion; stock re-rating
- ◆Advanced packaging (CoWoS, HBM) inflection (2023–2025)—TAM expansion at OSAT fabs
- ◆Semiconductor cycle downturn 2022–2023 (High probability)—medium-high impact; materialized and affected ENTG post-deal
- ◆China revenue attrition via Anji Technology & export controls (Medium 5-yr)—medium impact; emerging slower than feared
- ◆KMG synergy shortfall (Medium probability)—low-medium impact; partially materialized ($60–75M vs. $75–100M target)
- ◆Sub-IG credit rating limiting flexibility (Realized)—medium impact; was on path to IG when acquired
- ◆Technology disruption of CMP via atomic-layer-etch (Very Low)—very high impact; did not materialize through 2026
Full Memo Continues
5 more sections, locked
- ●Valuation Range & DCFBase/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
- ●Risk/Reward AssessmentPosition-sizing framework with explicit upside/downside skew and entry conditions.
- ●Management & Capital AllocationMulti-year capital-allocation track record, incentive alignment, and management readout.
- ●Monitoring FrameworkWhat to watch each quarter — leading indicators and inflection signals tracked by the analyst.
- ●Unresolved QuestionsOpen analyst questions and follow-up research items — the depth signal.
For Agents — $2 per memo
Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.
GET /api/v1/research/CCMP/memo Authorization: Bearer spt_...
Fund managers — coverage subscriptions launching soon. See marginofinsight.com.